NAD Precursors: A Questionable Redundancy.

Metabolites

Nestlé Institute of Health Sciences, Nestlé Research Ltd., EPFL Campus, Innovation Park, Building G, 1015 Lausanne, Switzerland.

Published: July 2022

The last decade has seen a strong proliferation of therapeutic strategies for the treatment of metabolic and age-related diseases based on increasing cellular NAD bioavailability. Among them, the dietary supplementation with NAD precursors-classically known as vitamin B3-has received most of the attention. Multiple molecules can act as NAD precursors through independent biosynthetic routes. Interestingly, eukaryote organisms have conserved a remarkable ability to utilize all of these different molecules, even if some of them are scarcely found in nature. Here, we discuss the possibility that the conservation of all of these biosynthetic pathways through evolution occurred because the different NAD precursors might serve specialized purposes.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9316858PMC
http://dx.doi.org/10.3390/metabo12070630DOI Listing

Publication Analysis

Top Keywords

nad precursors
12
nad
5
precursors questionable
4
questionable redundancy
4
redundancy decade
4
decade strong
4
strong proliferation
4
proliferation therapeutic
4
therapeutic strategies
4
strategies treatment
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!